Biotech · Private company
DalCor Pharmaceuticals
Track this companyFree. Adds DalCor Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- DalcetrapibPhase 3 · Acute Coronary SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPHASE3 · RECRUITING · started Oct 3, 2023ClinicalTrials.gov NCT05918861 · fetched Nov 12, 2026
- Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACSPHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02525939 · fetched Nov 12, 2026